Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

Anthony L Komaroff, Lucinda Bateman, Anthony L Komaroff, Lucinda Bateman

No abstract available

Keywords: COVID-19; SARS-CoV-2; myalgic encephalomyelitis/chronic fatigue syndrome; post-infectious fatigue syndrome; post-viral fatigue syndrome.

Conflict of interest statement

AK reports receiving personal fees from Serimmune Inc., Ono Pharma, and Deallus, and grants from the National Institutes of Health, for activities unrelated to the submitted work. LB is employed by the Bateman Horne Center which receives grants from the National Institutes of Health, and from BHC receives fees from Exagen, Inc., and Teva Pharmaceutical for activities unrelated to the submitted work.

References

    1. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network. MMWR Morb Mortal Wkly Rep. (2020) 69:993–8. 10.15585/mmwr.mm6930e1
    1. Carfi A, Bernabei R, Landi F, Group GAC-P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603–4. 10.1001/jama.2020.12603
    1. Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. (2020) 15:e0240784. 10.1371/journal.pone.0240784
    1. Davis H, Assaf G, McCorkell L, Wei H, Low R, Re'em Y, et al. Symptomatic description of long COVID through 7 months in an international cohort. medRxiv. (2020). 10.1101/2020.12.24.20248802
    1. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. (2011) 11:37. 10.1186/1471-2377-11-37
    1. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. (1985) 102:1–7. 10.7326/0003-4819-102-1
    1. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, et al. . Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. (1998) 173:475–81. 10.1192/bjp.173.6.475
    1. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575–8. 10.1136/
    1. Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. (2008) 61:43–8. 10.1136/jcp.2007.050054
    1. Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. (2006) 37:S39–46. 10.1016/S1386-6532(06)70010-5
    1. Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-Ebola signs and symptoms in U.S. survivors. N Engl J Med. (2015) 373:2483–4. 10.1056/NEJMc1506576
    1. Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, et al. . Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol. (2008) 2:477–99. 10.1348/174866407X218312
    1. Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. (2007) 38:1–6. 10.1016/j.jcv.2006.10.011
    1. Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, et al. . Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol. (2010) 91:893–7. 10.1099/vir.0.017590-0
    1. Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. (1990) 88:577–81. 10.1016/0002-9343(90)90520-N
    1. Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, et al. . Fatigue following acute Q-fever: a systematic literature review. PLoS ONE. (2016) 11:e0155884. 10.1371/journal.pone.0155884
    1. Nicolson GL, Gan R, Haier J. Multiple co-infections (mycoplasma, chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. (2003) 111:557–66. 10.1034/j.1600-0463.2003.1110504.x
    1. Litleskare S, Rortveit G, Eide GE, Hanevik K, Langeland N, Wensaas KA. Prevalence of irritable bowel syndrome and chronic fatigue 10 years after giardia infection. Clin Gastroenterol Hepatol. (2018) 16:1064–72.e4. 10.1016/j.cgh.2018.01.022
    1. Topol E, Verghese A, Fauci A. Fauci to Medscape: ‘We're All In It Together and We're Gonna Get Through It'. Medscape: (2020). Available online at:
    1. Institute of Medicine Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press; (2015).
    1. Nisenbaum R, Jones JF, Unger ER, Reyes M, Reeves WC. A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes. (2003) 1:49. 10.1186/1477-7525-1-49
    1. Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). (2005) 55:20–31. 10.1093/occmed/kqi013
    1. Bell DS, Jordan K, Robinson M. Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. Pediatrics. (2001) 107:994–8. 10.1542/peds.107.5.994
    1. Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. (2019) 322:499–500. 10.1001/jama.2019.8312
    1. Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. (2019) 14:562–72. 10.1007/s11682-018-0029-4
    1. Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, et al. . Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proc Natl Acad Sci USA. (2020) 117:15902–10. 10.1073/pnas.2003432117
    1. Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev. (2015) 57:30–45. 10.1016/j.neubiorev.2015.07.015
    1. VanElzakker MB. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med Hypotheses. (2013) 81:414–23. 10.1016/j.mehy.2013.05.034
    1. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. The neuroimmune basis of fatigue. Trends Neurosci. (2014) 37:39–46. 10.1016/j.tins.2013.10.003
    1. Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. (2016) 113:E5472–80. 10.1073/pnas.1607571113
    1. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. (2005) 39:584–9. 10.1016/j.freeradbiomed.2005.04.020
    1. Balinas C, Cabanas H, Staines D, Marshall-Gradisnik S. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med. (2019) 17:401. 10.1186/s12967-019-02155-4
    1. Campen CLMV, Rowe PC, Visser FC. Reductions in cerebral blood flow can be provoked by sitting in severe myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare (Basel). (2020) 8:394. 10.3390/healthcare8040394

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅